Jason A. Roberts spends much of his time researching Dosing, Intensive care medicine, Pharmacodynamics, Pharmacokinetics and Antibiotics. His work deals with themes such as Anesthesia, Antibacterial agent, Sepsis, Randomized controlled trial and Intensive care, which intersect with Dosing. His Intensive care medicine study incorporates themes from Antibiotic resistance, Drug resistance and Drug.
The various areas that Jason A. Roberts examines in his Pharmacodynamics study include Piperacillin, Clinical trial and Vancomycin. The concepts of his Pharmacokinetics study are interwoven with issues in Anesthesiology, Renal replacement therapy and Renal function. His study looks at the relationship between Antibiotics and topics such as Therapeutic drug monitoring, which overlap with Meropenem.
Jason A. Roberts mainly focuses on Pharmacokinetics, Dosing, Intensive care medicine, Antibiotics and Pharmacodynamics. The various areas that Jason A. Roberts examines in his Pharmacokinetics study include Anesthesia, Renal replacement therapy and Renal function. His Anesthesia research is multidisciplinary, incorporating elements of Interquartile range, Surgery, Sepsis and Antibacterial agent.
Jason A. Roberts combines subjects such as Vancomycin, Therapeutic drug monitoring, Intensive care and Meropenem with his study of Dosing. His Intensive care medicine research includes elements of Antimicrobial, Antibiotic resistance and Drug. His studies deal with areas such as Septic shock, Drug resistance and Pneumonia as well as Antibiotics.
His primary areas of investigation include Pharmacokinetics, Dosing, Pharmacodynamics, Intensive care medicine and Therapeutic drug monitoring. His research in Pharmacokinetics intersects with topics in Anesthesia, Loading dose, Renal replacement therapy and Renal function. His Dosing research incorporates elements of Amikacin, Antibiotics, Cefazolin, Regimen and Vancomycin.
His research integrates issues of Acinetobacter baumannii and Fosfomycin in his study of Pharmacodynamics. Jason A. Roberts has included themes like Psychological intervention, Antimicrobial stewardship and Antimicrobial in his Intensive care medicine study. His Therapeutic drug monitoring research integrates issues from Therapeutic index, Valganciclovir, Ganciclovir, Risk analysis and Transplantation.
Dosing, Therapeutic drug monitoring, Intensive care medicine, Antibiotics and Pharmacokinetics are his primary areas of study. His Dosing study results in a more complete grasp of Internal medicine. His Intensive care medicine study combines topics in areas such as Antimicrobial stewardship and Antimicrobial.
His study in Antibiotics focuses on Meropenem in particular. Jason A. Roberts mostly deals with Pharmacodynamics in his studies of Pharmacokinetics. His Pharmacodynamics research is multidisciplinary, incorporating perspectives in Gastroenterology, Pharmacotherapy and Drug.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil;Mark L. Metersky;Michael Klompas;John Muscedere.
Clinical Infectious Diseases (2016)
Pharmacokinetic issues for antibiotics in the critically ill patient.
Jason A. Roberts;Jeffrey Lipman.
Critical Care Medicine (2009)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts;Sanjoy K. Paul;Murat Akova;Matteo Bassetti.
Clinical Infectious Diseases (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A Roberts;Jason A Roberts;Mohd H Abdul-Aziz;Jeffrey Lipman;Jeffrey Lipman;Johan W Mouton.
Lancet Infectious Diseases (2014)
Effective dose from cone beam CT examinations in dentistry.
J. Roberts;Nicholas Drage;J. Davies;David William Thomas.
British Journal of Radiology (2009)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts;Jason A. Roberts;Carl M. J. Kirkpatrick;Michael S. Roberts;Thomas A. Robertson.
Journal of Antimicrobial Chemotherapy (2009)
Augmented renal clearance: implications for antibacterial dosing in the critically ill
Andrew A. Udy;Andrew A. Udy;Jason A. Roberts;Jason A. Roberts;Robert J. Boots;Robert J. Boots;David L. Paterson;David L. Paterson.
Clinical Pharmacokinectics (2010)
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial
Joel M. Dulhunty;Jason A. Roberts;Joshua S. Davis;Steven A. R. Webb.
Clinical Infectious Diseases (2013)
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Jason A Roberts;Jason A Roberts;Jeffrey Lipman;Jeffrey Lipman.
Clinical Pharmacokinectics (2006)
Antibiotic resistance : What's dosing got to do with it?
Jason A. Roberts;Peter Kruger;David L. Paterson;David L. Paterson;Jeffrey Lipman;Jeffrey Lipman.
Critical Care Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Royal Brisbane and Women's Hospital
University of Queensland
University of Queensland
Instituto de Salud Carlos III
University of Genoa
Université Libre de Bruxelles
Johns Hopkins University
Ghent University
University of Melbourne
University of Liverpool
Tencent (China)
Technion – Israel Institute of Technology
Applied Materials (United States)
University of Camerino
Victoria University of Wellington
University of Illinois at Urbana-Champaign
University of Minnesota
University of Bonn
Cornell University
International Maize and Wheat Improvement Center
Illumina (United States)
The University of Texas Health Science Center at San Antonio
University of Washington
Australian Institute of Marine Science
Queen's University
Emory University